CLYM insider transaction filings
Climb Bio, Inc. — 37 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-01. Screen CLYM transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-01 | 4 | Celebi Breanna Maurine — Director | Grant/award (A): 70,284 (derivative) @ $0 | EDGAR |
| 2026-07-01 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund II, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Grant/award (A): 70,284 (derivative) @ $0 | EDGAR |
| 2026-06-30 | 4 | Brennan Aoife — President and CEO, Director | Option exercise (M): 68,750 · Sale (S): 30,902 @ $13.17 · Option exercise (M): 68,750 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Levin Andrew David — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Thomas Stephen Basil — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Dunn Judith — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Cumbo Alexander — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Drapkin Kimberlee C — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund II, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | WILLIAMS DOUGLAS E — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-04-29 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund II, L.P. — Director RA Capital Nexus Fund III, L.P. — Director, 10% owner Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Grant/award (A): 2,106,000 (derivative) @ $9.50 | EDGAR |
| 2026-02-27 | 4 | Thomas Stephen Basil — Director | Sale (S): 33,687 @ $7.00 · Sale (S): 16,313 @ $7.01 | EDGAR |
| 2026-02-17 | 4 | Thomas Stephen Basil — Director | Sale (S): 90,000 @ $5.23 · Sale (S): 10,000 @ $5.81 | EDGAR |
| 2026-01-08 | 4 | Wilson Perrin Megan — Chief Business Officer | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2026-01-08 | 4 | ALTSCHULLER Susan — Chief Financial Officer | Grant/award (A): 142,500 (derivative) @ $0 | EDGAR |
| 2026-01-08 | 4 | Driscoll Cindy — Senior Vice President, Finance | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-01-08 | 4 | Brennan Aoife — President and CEO, Director | Grant/award (A): 700,000 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund II, L.P. — Director RA Capital Nexus Fund III, L.P. — Director, 10% owner Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 7,111 @ $3.50 | EDGAR |
| 2025-12-15 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund II, L.P. — Director RA Capital Nexus Fund III, L.P. — Director, 10% owner Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Disposition to issuer (D): 20,440,000 @ $0 · Purchase (P): 213,099 @ $2.18 · Purchase (P): 101,462 @ $2.86 · Grant/award (A): 20,440,000 (derivative) | EDGAR |
| 2025-10-01 | 4 | ALTSCHULLER Susan — Chief Financial Officer | Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2025-08-11 | 4 | Thomas Stephen Basil — Director | Grant/award (A): 100,375 @ $0 | EDGAR |
| 2025-07-01 | 4 | Thomas Stephen Basil — Director | Option exercise (M): 25,094 · Option exercise (M): 25,094 (derivative) @ $0 | EDGAR |
| 2025-07-01 | 4 | Brennan Aoife — President and CEO, Director | Option exercise (M): 68,750 · Sale (S): 20,618 @ $1.22 · Option exercise (M): 68,750 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Pimblett Emily — SVP, Finance & CAO | Option exercise (M): 5,000 · Sale (S): 1,242 @ $1.24 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Driscoll Cindy — Senior Vice President, Finance | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Dunn Judith — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Levin Andrew David — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Thomas Stephen Basil — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Cumbo Alexander — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Drapkin Kimberlee C — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund II, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | WILLIAMS DOUGLAS E — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-04-01 | 4 | Cumbo Alexander — Director | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2025-04-01 | 4 | Drapkin Kimberlee C — Director | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2025-04-01 | 4 | WILLIAMS DOUGLAS E — Director | Grant/award (A): 78,873 (derivative) @ $0 | EDGAR |
| 2025-03-27 | 4 | Thomas Stephen Basil — Director | Option exercise (M): 25,093 · Option exercise (M): 25,093 (derivative) @ $0 | EDGAR |
| 2025-03-20 | 4 | Pimblett Emily — SVP, Finance & CAO | Option exercise (M): 5,000 · Sale (S): 1,199 @ $1.31 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Climb Bio, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-14 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-01 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-06-12 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-11 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-06-08 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-05 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-05 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-28 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CLYM returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →